Business
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
- New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform-TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology,” publish
About this update from Conavi Medical Corp.
[{"type":"image","alt":"Conavi Medical Corp.","displaySize":"","headline":null,"caption":"Conavi Medical Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":168,"height":84,"url":"https://media.zenfs.com/en/globenewswire.com/7d9104cb9d85d935c2da2decad6f4c16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1os56Yi6fTjdCWe5mZbLcg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7d9104cb9d85d935c2da2decad6f4c16","width":168,"height":84}},"lazy":false},{"type":"text","content":"- New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform-","length":86,"tagName":"p"},{"type":"text","content":"TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality deep learning analysis and human experts: head-to-head comparison against histology,” published in Cardiovascular Research by the European Society of Cardiology.","length":482,"tagName":"p"},{"type":"text","content":"The study analyzed IVUS-OCT images and matched histological sections from 10 cadaveric human hearts, demonstrating that a histology-trained hybrid IVUS-OCT deep-learning classifier outperformed single-modality IVUS, single-modality OCT, and expert readers in plaque characterization, supporting the clinical and commercial value of a comprehensive hybrid imaging for enhancing treatment planning.","length":396,"tagName":"p"},{"type":"text","content":"The publication includes contributions from Dr. Brian Courtney, a pioneer in hybrid IVUS-OCT imaging and co-inventor of the foundational hybrid imaging technology that underpins Conavi’s platform. Co-authors included imaging experts in Canada, Europe and the USA, as well as artificial intelligence researchers at Queen Mary University of London.","length":346,"tagName":"p"},{"type":"text","content":"“Peer-reviewed academic research continues to reinforce the clinical value proposition behind Conavi’s technology platform,” said Tom Looby, Chief Executive Officer of Conavi Medical. “As the field moves toward more precise, image-guided coronary interventions, research highlighting the complementary stren...